Increasing Demand in Tier-2 and Tier-3 cities and further consolidation through Mergers and Acquisitions, has helped the Organised Sector to grow at a fast pace in the Indian Diagnostic Laboratory Market: Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit The disease burden rate at present is significantly higher in states with low healthcare infrastructure development, such as Assam, Uttar Pradesh, and other poorer northern states, as compared to states with advanced phases of development, such as Kerala and Goa. Due to lack of regulations the test pricing highly differs in this market. The National Pharmaceutical Pricing Agency (NPPA) analyzed bills from four major private hospitals and found out that diagnostics, at 15.56%, make up the second largest component on hospital bills. India is emerging as a major medical tourism destination, primarily due to its lower treatment costs as compared to other developed countries The Foreign Tourist Arrivals (FTAs) in India on medical visa during 2016 and 2017 were estimated at 4,27,014 and 4,95,056 respectively, registering a positive growth of 15.9%. Non-Communicable Diseases: India’s burden of non-communicable diseases (NCDs) is escalating. NCDs were typically present in individuals aged 55 years or older in many developed countries, but their onset occurs in India a decade earlier (≥45 years of age). Augmenting this problem further, are the issues of multiple chronic conditions and the fact that many remain undiagnosed due to lack of awareness and insufficient health-care access. At the same time, infectious and parasitic diseases still pose substantial challenges to the public health system in India, resulting in a double burden of disease. Regulations for Pricing: The Government is supporting states through ‘National Free Diagnostic Service Initiative’ to provide essential diagnostic services in public health facilities. The guidelines were brought out in July 2015 to provide states with a broad framework for implementing free drug initiatives. Along with this a guidance document for implementation of Free Laboratory Services in States/ UTs was released in August 2019 to guide them on planning and implementing Labs services in Hub and Spoke model. Medical Insurance: It is expected that by 2021, approximately 90 million Indian citizens would be above the age of 65. In the past, India had one of the highest rates of out of pocket expenditure on medical facilities however with the help of the government about 20% of the population has been able to gain access to healthcare services now. Most of the medical insurance available doesn’t pertain towards diagnostics however, that is expected to change in the near future as insurance penetration increase further in the country. Analysts at Ken Research in their latest publication “India Diagnostic Laboratories Market Outlook to FY’2025- By Government and Private Labs, By Radiology and Pathology, By Organized and Unorganized Players, By Business Model (Standalone, Hospital Based and Diagnostic Chains) , By Cities (Tier I, Tier II and Tier III cities) and By Payment Method (Out of Pocket Expenditure, Insurance based and Corporate Spending” believe that the market is highly fragmented with majority of its players from the unorganized sector. The trend of getting tested for sick-care will slowly change towards testing for well-being in the future. With the elderly population growing in the country, the demand for diagnostics is only going to grow further in the future. The market is expected to grow at a CAGR of 10.5% from FY’2020 to FY’2025. Key Segments Covered:- India Diagnostic Laboratories Market Revenue Segmentation by Government and Private Labs Government Labs Private Labs India Private Diagnostic Laboratories Market Revenue Segmentation by Pathology and Radiology Pathology Sector Radiology Sector Revenue Segmentation by Pathology Clinical Biology Hematology Surgical Pathology Histopathology Clinical Microbiology Molecular Biology Others Revenue Segmentation by Radiology X-rays Sonography MRI CT Scans Mammography PET Others Revenue Segmentation by Business Model Standalone Diagnostic Chains Hospital Based Labs Revenue Segmentation by Diagnostic Chains Regional Chains Large PAN-India Chains Revenue Segmentation by Tier I, II and III Cities Tier I cities Tier II cities Tier III cities Revenue Segmentation by Organized and Unorganized Players Revenue Segmentation by Type of Customers Referrals Walk Ins Corporate Client Revenue Segmentation by Payment Method Out of Pocket Expenditure Corporate Spending Insurance Key Target Audience:- Government Diagnostic Labs Private Diagnostic Labs Research Labs Medical Insurance Companies Medical Device Manufacturers Industry Associations Government Bodies Investors/VC’s Time Period Captured in the Report:- Historical Period: FY’2015-FY’2020 Forecast Period: FY’2020-FY’2025 Companies Mentioned:- Dr. Lal Pathlabs SRL Diagnostics Metropolis Healthcare Thyrocare Technologies Medall Healthcare Pvt Ltd Suraksha Diagnostics Pvt Ltd Suburban Diagnostics Neuberg Diagnostics Key Topics Covered in the Report:- Spread of Communicable and Non-Communicable Diseases in India Market Sizing Analysis of Diagnostic Labs in India Ecosystem of Diagnostic Labs in India Operating Models in India Diagnostic Labs Pricing Analysis in India Diagnostic Labs Market Value Chain Analysis of India Diagnostic Labs Market Decision Making Parameters for a Diagnostic Lab Issues and Challenges in the Industry Government Regulations in the Industry Segmentation by Radiology and Pathology Segmentation by Type of Business Model (Standalone, Hospital Based Labs and Diagnostic Chains) Upcoming Trends and Technologies in the Market Competition Scenario and Market Share Investment Model for a Franchise Lab in India Success Stories of Diagnostic Labs in India For More Information on the research report, refer to below link:– India Diagnostic Laboratories Market Related Reports:- Brazil Medical Device Market Outlook to 2025 – by Type of Device (Reagent for In-Vitro Diagnostics, Materials and Supplies, Laboratory Equipment and Others), Type of Business Activity (Import and Local Production), Channel of Sales (Distributor and Direct), Type of End User (Hospital, Clinics, and Diagnostic Lab Centers and Others) and By Region (South-East, South, North-East, Mid-West, and North) India POCT Market Outlook to 2023 – By Major Devices (Blood Glucose Testing Kits, Infectious Disease Testing Kits, Blood Gas Electrolytes, Pregnancy and Fertility Testing Kits, Cardio-Metabolic Monitoring, Anticoagulant Management, Cholesterol Testing Kits and Others), By End Users (Hospitals & Clinics, Consumers/ Individuals, Diagnostic Labs, Home Healthcare and Others), By Distribution Channel (Distributors and Direct Sales), By Consumables and Instruments and By Region Brazil Diagnostic Labs Market Outlook to 2025 – by Type of Labs (Single Independent and Chains), By Application (Clinical Analysis and Radiology), By Region(South-East, South, North-East, Mid-West, and North), By Revenue Source (Healthcare Plan Operators and Insurers, Out-of-Pocket and Public System) Contact Us:– Ken Research Ankur Gupta, Head Marketing & Communications Ankur@kenresearch.com +91-9015378249 Post Views: 10 Tags: Clinical Biochemistry Pathology Test India, Clinical Microbiology Pathology Test India, Covid-19 Impact India Diagnostic Laboratories Industry, Covid-19 Impact India Diagnostic Laboratories Market, Cronavirus Impact India Diagnostic Laboratories Industry, Cronavirus Impact India Diagnostic Laboratories Market, Diagnostic Laboratories Industry In India, Diagnostic Laboratories Market In India, Diagnostics Chains Market India, Dr. Lal Pathlabs Diagnostics Lab Market Revenue, Ecosystem of Diagnostic Labs India, Evaluation Study India Diagnostic Laboratories Market, Evaluation Summary Report India Diagnostic Laboratories Market, Evaluative Survey India Diagnostic Laboratories Market, Hematology Pathology Test India, Histopathology Test India, Hospital Based Labs Market India, India Clinical Microbiology Test Market, India Diagnostic Chains Market Size, India Diagnostic Hospital Based Labs Market, India Diagnostic Laboratories Due Diligence Report, India Diagnostic Laboratories Growth Strategy Market Report, India Diagnostic Laboratories Industry, India Diagnostic Laboratories Industry Research Report, India Diagnostic Laboratories Market, India Diagnostic Laboratories Market Analysis, India Diagnostic Laboratories Market Competition, India Diagnostic Laboratories Market Competition Benchmarking, India Diagnostic Laboratories Market Evaluation Report, India Diagnostic Laboratories Market Forecast, India Diagnostic Laboratories Market Future Outlook, India Diagnostic Laboratories Market Growth, India Diagnostic Laboratories Market Major Players, India Diagnostic Laboratories Market Research Report, India Diagnostic Laboratories Market Revenue, India Diagnostic Laboratories Market Revenue Forecasting, India Diagnostic Laboratories Market Shares, India Diagnostic Laboratories Market Size, India Diagnostic Laboratories Market Trends, India Diagnostic Laboratories Polyclinics Market, India Diagnostic Laboratories Standalone Centers Market, India Diagnostic Labs Industry, India Diagnostic Labs Market, India Histopathology Test Market, India Medical Device Manufacturers, India Molecular Biology Test Market, India Pathology Lab Market, India Pathology Lab Market Size, India Private Pathology Clinical Biochemistry Test Market, India Private Pathology Hematology Test Market, India Private Pathology Test Market, India Private Pathology Tests Market Size, India Private Radiology CT Scans Test Market, India Private Radiology Mammography Test Market, India Private Radiology MRI Test Market, India Private Radiology PET Test Market, India Private Radiology Sonography Test Market, India Private Radiology Test Market, India Private Radiology Tests Market Size, India Private Radiology X-Rays Test Market, India Radiology Lab Market, India Radiology Lab Market Size, India Surgical Pathology Test Market, Industry Research Report Of India Diagnostic Laboratories, Market Research Report Of India Diagnostic Laboratories, Medall Healthcare Diagnostics Lab Market Shares, Medical Insurance in Diagnostic Sector India, Medical Tourism India, Metropolis Healthcare Diagnostics Lab Market Revenue, Molecular Biology Pathology Test India, Neuberg Diagnostic Lab Market Shares, Organised Diagnostic Labs Market Size India, Social Evaluation Research India Diagnostic Laboratories Market, SRL Diagnostics Lab Market Share, Standalone Diagnostic Clinics Market India, Suburban Diagnostics Lab Market Revenue, Suraksha Diagnostics Lab Market Revenue, Surgical Pathology Test India, Telemedicine in India, Thyrocare Technologies Diagnostics Lab Market Sales, Type of Pathology Tests India, Types of Radiology Tests India, Unorganized Diagnostic Labs Market Share India, Write An Evaluation Report On India Diagnostic Laboratories Market